Trial objective and outcomes The objective of this trial was to determine whether a 3-week treatment with the GLP-1 RA dulaglutide compared with placebo reduces fluid intake in patients with primary polydipsia
Metformin, an inexpensive and widely-used medication for type 2 diabetes, is one such alternative
The mean duration of follow-up was 39.9 months (SD = 9.3 months) in the semaglutide 2.4 mg group and 39.7 months (SD = 9.5 months) in the placebo group
Methionine, Inositol, and Choline (MIC): Also called fat burner injections, these compounds help break down fat more efficiently and support liver detoxification
produce amid cyclospora outbreak02:27 | July 16, 2026 Health Matters: Toronto air quality ranked worst in the world02:11 | July 15, 2026 Cyclospora outbreak source not confirmed, health officials investigating link to lettuce, greens02:04 | July 14, 2026 Health Matters: B.C